Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (18661)	8/7/2010 11:32:05 AM
From: J_F_Shepard	Read Replies (2) \| Respond to of 42652

Do you have a link you consider satisfactory in it's conclusions...? You seemed to have been quoting older work..

To: Lane3 who wrote (18661)	8/7/2010 11:53:42 AM
From: J_F_Shepard	Read Replies (1) \| Respond to of 42652

Effect of Statins on Risk of Coronary Disease A Meta-analysis of Randomized Controlled Trials "Context: Lowering low-density lipoprotein cholesterol (LDL-C) is known to reduce risk of recurrent coronary heart disease in middle-aged men. However, this effect has been uncertain in elderly people and women. "Conclusions Our meta-analysis indicates that reduction in LDL-C associated with statin drug treatment decreases the risk of coronary heart disease and all-cause mortality. The risk reduction was similar for men and women and for elderly and middle-aged persons. JAMA. 1999;282:2340-2346 www.jama.com"